应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GPCR STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD
盘前交易 07-09 08:10:41 EDT
18.74
+0.01
+0.03%
盘前
19.08
+0.34
+1.84%
08:00 EDT
最高
19.20
最低
18.64
成交量
65.05万
今开
18.82
昨收
18.73
日振幅
2.99%
总市值
10.78亿
流通市值
9.13亿
总股本
5,754万
成交额
1,226万
换手率
1.34%
流通股本
4,871万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
硕迪生物盘中异动 急速下跌5.08%报19.33美元
市场透视 · 07-07 17:31
硕迪生物盘中异动 急速下跌5.08%报19.33美元
硕迪生物盘中异动 早盘股价大涨5.11%报23.23美元
市场透视 · 06-24
硕迪生物盘中异动 早盘股价大涨5.11%报23.23美元
硕迪生物盘中异动 股价大涨5.22%报22.87美元
市场透视 · 06-23
硕迪生物盘中异动 股价大涨5.22%报22.87美元
摩根大通证券公司:重申Structure Therapeutics(GPCR.US)评级,由优于大市调整至优于大市评级,
智通财经 · 06-23
摩根大通证券公司:重申Structure Therapeutics(GPCR.US)评级,由优于大市调整至优于大市评级,
硕迪生物盘中异动 急速跳水5.00%
市场透视 · 06-16
硕迪生物盘中异动 急速跳水5.00%
硕迪生物盘中异动 股价大涨5.06%报22.94美元
市场透视 · 06-11
硕迪生物盘中异动 股价大涨5.06%报22.94美元
硕迪生物盘中异动 大幅上涨5.17%
市场透视 · 06-10
硕迪生物盘中异动 大幅上涨5.17%
硕迪生物盘中异动 早盘急速下挫5.36%
市场透视 · 05-27
硕迪生物盘中异动 早盘急速下挫5.36%
硕迪生物盘中异动 大幅上涨5.61%报25.80美元
市场透视 · 05-16
硕迪生物盘中异动 大幅上涨5.61%报25.80美元
异动解读 | 硕迪生物股价盘中大跌5.73%,分析师下调目标价
异动解读 · 05-14
异动解读 | 硕迪生物股价盘中大跌5.73%,分析师下调目标价
异动解读 | 硕迪生物盘中大跌5.73%,分析师下调目标价
异动解读 · 05-14
异动解读 | 硕迪生物盘中大跌5.73%,分析师下调目标价
硕迪生物盘中异动 早盘股价大跌5.32%报22.62美元
市场透视 · 05-14
硕迪生物盘中异动 早盘股价大跌5.32%报22.62美元
异动解读 | Structure Therapeutics盘前大涨9.50%,分析师维持买入评级
异动解读 · 05-12
异动解读 | Structure Therapeutics盘前大涨9.50%,分析师维持买入评级
HC Wainwright & Co.:维持Structure Therapeutics(GPCR.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。
金融界 · 05-12
HC Wainwright & Co.:维持Structure Therapeutics(GPCR.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。
硕迪生物盘中异动 股价大跌5.17%
市场透视 · 05-06
硕迪生物盘中异动 股价大跌5.17%
硕迪生物盘中异动 股价大涨5.00%报27.21美元
市场透视 · 04-30
硕迪生物盘中异动 股价大涨5.00%报27.21美元
硕迪生物盘中异动 股价大涨5.46%报24.91美元
市场透视 · 04-29
硕迪生物盘中异动 股价大涨5.46%报24.91美元
硕迪生物盘中异动 股价大涨5.03%报24.20美元
市场透视 · 04-23
硕迪生物盘中异动 股价大涨5.03%报24.20美元
硕迪生物盘中异动 股价大跌5.37%
市场透视 · 04-22
硕迪生物盘中异动 股价大跌5.37%
硕迪生物盘中异动 早盘股价大涨5.51%报22.96美元
市场透视 · 04-21
硕迪生物盘中异动 早盘股价大涨5.51%报22.96美元
加载更多
公司概况
公司名称:
STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD
所属市场:
NASDAQ
上市日期:
--
主营业务:
硕迪生物公司于2019年2月在开曼群岛成立,在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司,旨在开发和提供新型口服疗法,以治疗各种慢性疾病,满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识,使公司能够开发口服小分子疗法,用于治疗各种疾病,包括影响代谢、心血管和肺系统的疾病。
发行价格:
--
{"stockData":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":18.735,"timestamp":1752004800000,"preClose":18.73,"halted":0,"volume":650502,"hourTrading":{"tag":"盘前","latestPrice":19.08,"preClose":18.735,"latestTime":"08:00 EDT","volume":64,"amount":1195.751936,"timestamp":1752062431829},"delay":0,"floatShares":48705939,"shares":57536749,"eps":-2.590061,"marketStatus":"盘前交易","change":0.005,"latestTime":"07-09 08:10:41 EDT","open":18.82,"high":19.2,"low":18.64,"amount":12264894.512514,"amplitude":0.029899,"askPrice":19.09,"askSize":300,"bidPrice":17.68,"bidSize":220,"shortable":3,"etf":0,"ttmEps":-2.590061,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752067800000},"marketStatusCode":1,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":18.735,"preHourTrading":{"tag":"盘前","latestPrice":19.08,"preClose":18.735,"latestTime":"08:00 EDT","volume":64,"amount":1195.751936,"timestamp":1752062431829},"postHourTrading":{"tag":"盘后","latestPrice":18.5196,"preClose":18.735,"latestTime":"19:39 EDT","volume":11280,"amount":211307.0456,"timestamp":1752017946399},"volumeRatio":1.3723856188535442,"impliedVol":0.7722,"impliedVolPercentile":0.3735},"requestUrl":"/m/hq/s/GPCR","defaultTab":"news","newsList":[{"id":"2549543315","title":"硕迪生物盘中异动 急速下跌5.08%报19.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549543315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549543315?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:31","pubTimestamp":1751909495,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日01时31分,硕迪生物股票出现波动,股价大幅下挫5.08%。截至发稿,该股报19.33美元/股,成交量24.2063万股,换手率0.42%,振幅6.16%。硕迪生物股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Mustang Bio, Inc.、Vor Biopharma Inc.、Pelthos Therapeutics Inc.涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为5913.33%、1237.38%、899.08%,振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.,振幅分别为306.72%、233.18%、99.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708013135a69b626e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708013135a69b626e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2545315452","title":"硕迪生物盘中异动 早盘股价大涨5.11%报23.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545315452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545315452?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:06","pubTimestamp":1750777599,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时06分,硕迪生物股票出现波动,股价快速拉升5.11%。截至发稿,该股报23.23美元/股,成交量18.1051万股,换手率0.31%,振幅6.77%。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242306399529c0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242306399529c0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2545485804","title":"硕迪生物盘中异动 股价大涨5.22%报22.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545485804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545485804?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:19","pubTimestamp":1750688366,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时19分,硕迪生物股票出现波动,股价大幅上涨5.22%。截至发稿,该股报22.87美元/股,成交量32.0242万股,换手率0.56%,振幅5.94%。硕迪生物股票所在的生物技术行业中,整体涨幅为0.46%。其相关个股中,Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大,Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃,换手率分别为1624.09%、1324.19%、446.58%,振幅较大的相关个股有Impact Biomedical, Inc.、Immatics N V C/Wts 01/07/2025 、Indaptus Therapeutics, Inc.,振幅分别为140.85%、71.02%、64.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623221927978b617d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623221927978b617d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599","IBO"],"gpt_icon":0},{"id":"2545412264","title":"摩根大通证券公司:重申Structure Therapeutics(GPCR.US)评级,由优于大市调整至优于大市评级,","url":"https://stock-news.laohu8.com/highlight/detail?id=2545412264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545412264?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:13","pubTimestamp":1750684384,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","159848","BK4599","GPCR","BK4007","LENZ","BK4539","399975"],"gpt_icon":0},{"id":"2544988978","title":"硕迪生物盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544988978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544988978?lang=zh_cn&edition=full","pubTime":"2025-06-17 03:55","pubTimestamp":1750103707,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日03时55分,硕迪生物股票出现异动,股价快速下跌5.00%。截至发稿,该股报20.60美元/股,成交量47.3506万股,换手率0.82%,振幅6.33%。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061703550797824428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061703550797824428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2542539731","title":"硕迪生物盘中异动 股价大涨5.06%报22.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542539731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542539731?lang=zh_cn&edition=full","pubTime":"2025-06-12 00:48","pubTimestamp":1749660499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日00时48分,硕迪生物股票出现异动,股价急速上涨5.06%。截至发稿,该股报22.94美元/股,成交量43.0956万股,换手率0.75%,振幅4.63%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-46.90百万美元,每股收益-0.82美元,毛利-686976.74美元,市盈率-8.67倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061200482095181c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061200482095181c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2542346812","title":"硕迪生物盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542346812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542346812?lang=zh_cn&edition=full","pubTime":"2025-06-10 23:24","pubTimestamp":1749569055,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日23时24分,硕迪生物股票出现异动,股价快速拉升5.17%。截至发稿,该股报21.57美元/股,成交量28.1777万股,换手率0.49%,振幅5.41%。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610232415a4a2240f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610232415a4a2240f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2538046228","title":"硕迪生物盘中异动 早盘急速下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538046228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538046228?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:00","pubTimestamp":1748354410,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时00分,硕迪生物股票出现异动,股价急速下跌5.36%。截至发稿,该股报23.24美元/股,成交量14.2363万股,换手率0.25%,振幅6.57%。机构评级方面,在所有14家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220010a6ef0b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220010a6ef0b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2535313942","title":"硕迪生物盘中异动 大幅上涨5.61%报25.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313942?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:37","pubTimestamp":1747402674,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时37分,硕迪生物股票出现波动,股价大幅上涨5.61%。截至发稿,该股报25.80美元/股,成交量4.5946万股,换手率0.08%,振幅7.33%。机构评级方面,在所有14家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213754aa2c912a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213754aa2c912a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"1138233875","title":"异动解读 | 硕迪生物股价盘中大跌5.73%,分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1138233875","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138233875?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:24","pubTimestamp":1747236288,"startTime":"0","endTime":"0","summary":"硕迪生物今日盘中股价大跌5.73%,引发市场关注。该公司专注于开发用于治疗慢性疾病的新型口服小分子药物,但近期股价表现不佳。导致股价下跌的一个可能原因是分析师评级的变化。HC Wainwright & Co.虽然维持了对硕迪生物的\"买入\"评级,但将目标价从80美元下调至75美元。此外,硕迪生物的最新财报数据也可能影响了投资者信心。作为一家处于临床阶段的生物制药公司,硕迪生物仍在进行研发投入,这种财务状况并不罕见。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"1153155592","title":"异动解读 | 硕迪生物盘中大跌5.73%,分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1153155592","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153155592?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:24","pubTimestamp":1747236286,"startTime":"0","endTime":"0","summary":"今日盘中,硕迪生物股价大幅下跌5.73%,引起市场广泛关注。该公司是一家专注于开发新型口服小分子治疗药物的临床阶段生物制药公司。消息面上,投资银行HC Wainwright & Co.发布了最新的研究报告,维持对硕迪生物的\"买入\"评级,但将目标价从80.00美元下调至75.00美元。同时,整个生物技术行业今日也呈现小幅下跌趋势,跌幅为0.50%,这在一定程度上也可能影响了硕迪生物的股价表现。投资者应密切关注公司未来的研发进展和行业动态,以评估其长期投资价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 硕迪生物盘中大跌5.73%,分析师下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2535007143","title":"硕迪生物盘中异动 早盘股价大跌5.32%报22.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535007143?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:04","pubTimestamp":1747235056,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时04分,硕迪生物股票出现波动,股价快速下跌5.32%。截至发稿,该股报22.62美元/股,成交量19.4559万股,换手率0.34%,振幅8.31%。机构评级方面,在所有14家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.50%。该信息摘要如下:HC Wainwright & Co.:维持Structure Therapeutics评级,由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230416aa2c8eaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514230416aa2c8eaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"1146194349","title":"异动解读 | Structure Therapeutics盘前大涨9.50%,分析师维持买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1146194349","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146194349?lang=zh_cn&edition=full","pubTime":"2025-05-12 20:16","pubTimestamp":1747052182,"startTime":"0","endTime":"0","summary":"周一盘前,Structure Therapeutics Inc股价大幅上涨9.50%,引发市场关注。消息面上,知名投资银行HC Wainwright & Co.发布最新研究报告,维持对Structure Therapeutics的\"买入\"评级。分析认为,尽管目标价略有下调,但HC Wainwright & Co.维持\"买入\"评级显示了对公司基本面的持续信心。这一积极信号可能是推动Structure Therapeutics股价在盘前大幅上涨的主要原因。投资者似乎对公司的长期发展前景保持乐观,并认为当前股价可能低估了公司的潜在价值。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Structure Therapeutics盘前大涨9.50%,分析师维持买入评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"gpt_icon":0},{"id":"2534931222","title":"HC Wainwright & Co.:维持Structure Therapeutics(GPCR.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534931222","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534931222?lang=zh_cn&edition=full","pubTime":"2025-05-12 20:13","pubTimestamp":1747051981,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Structure Therapeutics(GPCR.US)评级,由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/12201350321494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","GPCR"],"gpt_icon":0},{"id":"2533266871","title":"硕迪生物盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533266871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533266871?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:27","pubTimestamp":1746552431,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时27分,硕迪生物股票出现波动,股价急速跳水5.17%。截至发稿,该股报26.12美元/股,成交量60.6472万股,换手率1.05%,振幅5.77%。机构评级方面,在所有14家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为5.64%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012711a6d54994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507012711a6d54994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2531052139","title":"硕迪生物盘中异动 股价大涨5.00%报27.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531052139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531052139?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:48","pubTimestamp":1746024495,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时48分,硕迪生物股票出现波动,股价快速上涨5.00%。截至发稿,该股报27.21美元/股,成交量45.9066万股,换手率0.80%,振幅6.72%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.23亿美元,每股收益-2.33美元,毛利-2.60百万美元,市盈率-11.49倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为0.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224815974bb277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224815974bb277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2531758632","title":"硕迪生物盘中异动 股价大涨5.46%报24.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531758632?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:44","pubTimestamp":1745934289,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时44分,硕迪生物股票出现异动,股价大幅上涨5.46%。截至发稿,该股报24.91美元/股,成交量4.824万股,换手率0.08%,振幅2.43%。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为1.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429214449a6cd6d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2529268009","title":"硕迪生物盘中异动 股价大涨5.03%报24.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529268009?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:10","pubTimestamp":1745417434,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时10分,硕迪生物股票出现波动,股价大幅上涨5.03%。截至发稿,该股报24.20美元/股,成交量15.5897万股,换手率0.27%,振幅4.26%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.23亿美元,每股收益-2.33美元,毛利-2.60百万美元,市盈率-10.31倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2529859539","title":"硕迪生物盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529859539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529859539?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:54","pubTimestamp":1745337275,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时54分,硕迪生物股票出现波动,股价快速下挫5.37%。截至发稿,该股报21.86美元/股,成交量52.9245万股,换手率0.92%,振幅5.80%。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体涨幅为1.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2529807202","title":"硕迪生物盘中异动 早盘股价大涨5.51%报22.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529807202?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:47","pubTimestamp":1745243261,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时47分,硕迪生物股票出现异动,股价急速上涨5.51%。截至发稿,该股报22.96美元/股,成交量8.2101万股,换手率0.14%,振幅8.20%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.23亿美元,每股收益-2.33美元,毛利-2.60百万美元,市盈率-9.72倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121474194dcef28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121474194dcef28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.structuretx.com","stockEarnings":[{"period":"1week","weight":-0.0865},{"period":"1month","weight":-0.1133},{"period":"3month","weight":0.2269},{"period":"6month","weight":-0.3071},{"period":"1year","weight":-0.4968},{"period":"ytd","weight":-0.3092}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕迪生物公司于2019年2月在开曼群岛成立,在美国和中国设有运营子公司。该公司是一家临床阶段的全球生物制药公司,旨在开发和提供新型口服疗法,以治疗各种慢性疾病,满足医疗需求。公司的差异化技术平台利用基于结构的药物发现和计算化学专业知识,使公司能够开发口服小分子疗法,用于治疗各种疾病,包括影响代谢、心血管和肺系统的疾病。","exchange":"NASDAQ","name":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","nameEN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD,GPCR,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票老虎国际,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票行情,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股价,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股市,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票价格,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票交易,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票购买,STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD(GPCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}